As­traZeneca picks win­ner in in­haled JAK 'bake-of­f' while sweep­ing Alex­ion drug out

As­traZeneca is push­ing an Alex­ion lega­cy drug out of the pipeline as part of the rou­tine quar­ter­ly house-clean­ing ex­er­cise.

ALXN1830, an FcRn block­er that Alex­ion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER